Infection of naive target cells with virus-like particles: implications for the function of ebola virus VP24. - Wikidata - wikimedia - TriplyDB

Infection of naive target cells with virus-like particles: implications for the function of ebola virus VP24.

Infection of naive target cells with virus-like particles: implications for the function of ebola virus VP24.

http://www.wikidata.org/entity/Q34717930

about

Cryo-electron tomography of Marburg virus particles and their morphogenesis within infected cells Nasal delivery of an adenovirus-based vaccine bypasses pre-existing immunity to the vaccine carrier and improves the immune response in mice Filoviral immune evasion mechanisms Marburg Virus Evades Interferon Responses by a Mechanism Distinct from Ebola Virus Crystal structure of the C-terminal domain of Ebola virus VP30 reveals a role in transcription and nucleocapsid association The Marburg virus VP24 protein interacts with Keap1 to activate the cytoprotective antioxidant response pathway Progress towards the treatment of Ebola haemorrhagic fever.Flavonoids as multi-target inhibitors for proteins associated with Ebola virus: in-silico discovery using virtual screening and molecular docking studies.Flavonoids as Multi-target Inhibitors for Proteins Associated with Ebola Virus: In Silico Discovery Using Virtual Screening and Molecular Docking Studies.Development and characterization of a mouse model for Marburg hemorrhagic fever Enhanced protection against Ebola virus mediated by an improved adenovirus-based vaccine Identification of essential filovirion-associated host factors by serial proteomic analysis and RNAi screen.Establishment of fruit bat cells (Rousettus aegyptiacus) as a model system for the investigation of filoviral infection Oligomerization of Ebola virus VP40 is essential for particle morphogenesis and regulation of viral transcription Viral and host proteins that modulate filovirus budding The Ebola virus VP24 protein prevents hnRNP C1/C2 binding to karyopherin α1 and partially alters its nuclear import.A novel life cycle modeling system for Ebola virus shows a genome length-dependent role of VP24 in virus infectivity How Ebola virus counters the interferon system.Filovirus replication and transcription.Determination of specific antibody responses to the six species of ebola and Marburg viruses by multiplexed protein microarrays Analysis of the highly diverse gene borders in Ebola virus reveals a distinct mechanism of transcriptional regulation.Efficient cellular release of Rift Valley fever virus requires genomic RNA.Contribution of Sec61α to the life cycle of Ebola virus.Ebola virus enters host cells by macropinocytosis and clathrin-mediated endocytosis.A virus-like particle system identifies the endonuclease domain of Crimean-Congo hemorrhagic fever virus.Backs against the wall: novel and existing strategies used during the 2014-2015 Ebola virus outbreak Improving attrition rates in Ebola virus drug discovery.Assessing the contribution of interferon antagonism to the virulence of West African Ebola viruses Genus-specific recruitment of filovirus ribonucleoprotein complexes into budding particles Inclusion bodies are a site of ebolavirus replication Minigenomes, transcription and replication competent virus-like particles and beyond: reverse genetics systems for filoviruses and other negative stranded hemorrhagic fever viruses Airway delivery of an adenovirus-based Ebola virus vaccine bypasses existing immunity to homologous adenovirus in nonhuman primates.Modeling the lifecycle of Ebola virus under biosafety level 2 conditions with virus-like particles containing tetracistronic minigenomes.Role of Ebola virus VP30 in transcription reinitiation.Polyamines and Hypusination Are Required for Ebolavirus Gene Expression and Replication.Functional Characterization of Adaptive Mutations during the West African Ebola Virus Outbreak.Reverse genetics systems as tools for the development of novel therapies against filoviruses.Ebola virus outbreak, updates on current therapeutic strategies.Development of experimental and early investigational drugs for the treatment of Ebola virus infections.Small Animal Models for Studying Filovirus Pathogenesis.

P2860

Q21090169-CD72FD9C-5F34-480D-891A-D61F75763979 Q21092172-919545FA-B298-43E5-8DA2-492E5F16B825 Q22305519-76134D48-DC80-403A-AB15-A01A6C62E110 Q27490714-82384A3F-D738-4159-B86F-2E51F2F2D0CE Q27641049-46FDE499-A68F-48DB-A3C6-CCB1B4174F82 Q27682227-8DE74BBE-FB86-424B-9A2D-D60E8289121F Q30230272-1620CAB5-5FDF-4D8D-A957-8C348E2C7122 Q30371564-35610DBF-D79B-4FD0-AE82-9A92802CE5F8 Q30378093-F38FF12C-B830-43C5-86DC-0C259EC9D3EA Q33384111-1167B519-18B2-43D2-A06D-9AD6D7665061 Q33434415-ED1E4D10-A470-4A48-BD7C-EC97AC952F43 Q33655087-0B610198-26DE-447C-A75E-F3E13C4D1470 Q33680083-8D931145-21B7-4CCA-B3D5-3FE04701AECD Q33966568-DFA5F91E-24F3-4C5C-9006-233689083C0A Q34070413-062E0EE5-4E32-4A69-B81C-2CFA84C35150 Q34222991-E3BF7185-764E-415D-87DC-FEF264E0789D Q34262347-1AE799B7-129C-4FF9-B1B8-65E085C4EF44 Q34298213-BED194D8-9F4C-48C3-B806-713502E42F90 Q34375243-0AE2B4B7-BED9-4236-A8A1-7FBB9FB0A7D6 Q34593045-70B8AE35-E924-4297-8BAE-2F5F9EC6F1B2 Q34593723-85EAFDC8-429B-4B2D-BA98-D8CD3604BDD2 Q34704620-D9A2D548-99C7-4D98-9183-1B2A3E4EE435 Q35299870-B66737BD-3EF2-4327-9797-7D47FEA445E2 Q35299912-B6389404-8CB2-4CE2-BAE1-AF74C92F570D Q35587097-026E2746-36AC-47C2-B1E6-A8CAC3C56A2D Q35598919-669B0078-130F-4219-B5BD-471E80890F6D Q35678774-6606794E-79E8-4DBE-BDA2-E65635AAF061 Q35922893-39CD2257-06CD-47CB-B669-AFDC69B738D2 Q35961320-38CEBD91-DEC1-4F5D-80E0-7B9F3BAE5818 Q36363434-F476D5BA-42B7-459F-9DBD-EE948910A198 Q36650409-9E84C3EC-EBAE-4B3B-83B1-9D61E7915334 Q36759754-ADD8448E-3E5F-4C65-B3C6-7B3C5718ECCB Q36788332-FC310E3D-5F8B-406E-8283-3507228DA5BA Q36994598-A291160A-545C-4F38-9965-1DED512B9860 Q37168685-4D5FE371-3309-41A5-A737-8474D8616341 Q37560781-B633B38C-AB7C-4FFF-B2AC-57E4AE4C6911 Q38244444-A325AAC2-D1A6-4EBF-836E-1E0C2EF7C8C6 Q38473251-0DA65686-3399-483D-A126-910FBF14AF24 Q38524949-B4E1A339-1A2E-4515-B171-F9FA045A374E Q38666317-9A1A72CA-C06F-4AAC-9D94-75E56B3CE0FE

P2860

Infection of naive target cells with virus-like particles: implications for the function of ebola virus VP24.

http://www.wikidata.org/entity/Q34717930

description

2006 nî lūn-bûn

@nan

2006 թուականի Յուլիսին հրատարակուած գիտական յօդուած

@hyw

2006 թվականի հուլիսին հրատարակված գիտական հոդված

@hy

2006年の論文

@ja

2006年論文

@yue

2006年論文

@zh-hant

2006年論文

@zh-hk

2006年論文

@zh-mo

2006年論文

@zh-tw

2006年论文

@wuu

name

Infection of naive target cell ...... function of ebola virus VP24.

@ast

Infection of naive target cell ...... function of ebola virus VP24.

@en

Infection of naive target cell ...... function of ebola virus VP24.

@nl

type

label

Infection of naive target cell ...... function of ebola virus VP24.

@ast

Infection of naive target cell ...... function of ebola virus VP24.

@en

Infection of naive target cell ...... function of ebola virus VP24.

@nl

prefLabel

Infection of naive target cell ...... function of ebola virus VP24.

@ast

Infection of naive target cell ...... function of ebola virus VP24.

@en

Infection of naive target cell ...... function of ebola virus VP24.

@nl

P1433

Q34717930-39D7F2C9-798C-4606-856A-B1B536219F9F

P1476

Q34717930-B543EDD0-4138-4EBE-9E84-915D8A007278

P2093

Q34717930-10AFCFAA-8008-4A20-A09A-2B3253861A54

Q34717930-2BEEFB3F-8F63-4829-BEB9-060F734CE407

Q34717930-533ECE6E-9D77-4BC0-8084-448D7231A2C6

Q34717930-7B1F56EA-527E-44B0-8341-45A44F24A408

Q34717930-FB860456-1492-4765-8F67-01D03DAB3E57

P2860

Q34717930-03FCEC04-F43F-4683-A387-8CCFB042BF24

Q34717930-11EC8C28-70D2-44EE-918B-3FB031E27EE4

Q34717930-1CB22F4A-C906-4F6D-A16E-1585B192369B

Q34717930-2FC77960-3B79-461C-A8AD-96A28D35C86D

Q34717930-3177DD48-C1B9-4A1E-9EBB-179FCC07FCC4

Q34717930-411BE630-48C3-4879-A1E1-6378F5A926D1

Q34717930-4748BC5B-4439-4217-BB17-3939839D9900

Q34717930-85BAF46D-E78D-439C-B2E1-DC45C0C13081

Q34717930-86012CE8-9446-4CC0-BD00-89E8DAEC3A89

Q34717930-92CA656E-8C69-4446-BD3B-84417EB7E512

P304

Q34717930-E86C96C4-B432-4E3E-A5F4-DA512C3025AA

P31

Q34717930-2F500266-8D0A-4B87-AFD1-5DE7A60BE127

P356

Q34717930-93284C3B-9700-42E6-85A6-C09289CC989F

P407

Q34717930-233FE575-3A0F-423C-97DA-CBE61D5CAAE6

P433

Q34717930-493861C5-B9E3-4788-BED5-59CF5C5852DB

P478

Q34717930-02142B5D-617E-4159-AC8B-E2402FBA6C82

P50

Q34717930-56D58E87-2D1A-421C-903C-2E800786076B

Q34717930-6F1EDC58-A521-4FFF-9B1C-3EA9FA583FAF

Q34717930-B8C5E2EC-1FF1-43CD-AD6F-524AD38D45B8

Q34717930-C432626B-5D43-4E50-BDDE-F5C46220C771

Q34717930-E7FC0D00-E0EB-4002-964B-85DE0E7213AB

P577

Q34717930-3123A6B9-C7E2-4BD8-9B25-C98E48CCAF7D

P698

Q34717930-450C29D8-7758-4DBF-8914-D5A5AF8ED046

P921

Q34717930-ED1A5583-8A44-453B-A669-07ADB0D60110

P932

Q34717930-28F58FDA-88A3-4DEC-A49D-C029D8B1BBAE

P356

P1433

Journal of Virology

P1476

Infection of naive target cell ...... function of ebola virus VP24.

@en

P2093

Allison Groseth

http://www.w3.org/2001/XMLSchema#string

Bettina Hartlieb

http://www.w3.org/2001/XMLSchema#string

Larissa Kolesnikova

http://www.w3.org/2001/XMLSchema#string

Sandra Bamberg

http://www.w3.org/2001/XMLSchema#string

Steven Theriault

http://www.w3.org/2001/XMLSchema#string

P2860

Comparison of the transcription and replication strategies of marburg virus and Ebola virus by using artificial replication systems

RNA polymerase I-driven minigenome system for Ebola viruses.

Efficient recovery of infectious vesicular stomatitis virus entirely from cDNA clones.

Biochemical and functional characterization of the Ebola virus VP24 protein: implications for a role in virus assembly and budding.

Transcription and replication of nonsegmented negative-strand RNA viruses.

Therapy and prophylaxis of Ebola virus infections.

Production of novel ebola virus-like particles from cDNAs: an alternative to ebola virus generation by reverse genetics.

Plasmid-driven formation of influenza virus-like particles.

Identification of the lymphocytic choriomeningitis virus (LCMV) proteins required to rescue LCMV RNA analogs into LCMV-like particles.

Regulation of the interferon system: evidence that Vero cells have a genetic defect in interferon production.

P304

7260-7264

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1128/JVI.00051-06

http://www.w3.org/2001/XMLSchema#string

P407

P433

14

http://www.w3.org/2001/XMLSchema#string

P478

80

http://www.w3.org/2001/XMLSchema#string

P50

P577

2006-07-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

16809331

http://www.w3.org/2001/XMLSchema#string

P921

P932

1489071

http://www.w3.org/2001/XMLSchema#string